跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,201 条关于
“HCW11-006”
全部
8,201
临床试验
2,927
药物
4,793
机构
5
资讯
476
10天前
HCW Biologics Signs Exclusive Distribution Deal with Akron Biotech for CAR-T Manufacturing Reagent HCW11-006
7个月前
HCW Biologics and WY Biotech Launch Joint Venture Trimmune to Advance Cancer Immunotherapy HCW11-006
去年
HCW Biologics Achieves 100% Survival Rate with Novel T-Cell Engagers in Pancreatic Cancer Preclinical Study
去年
HCW Biologics Secures $5 Million in Follow-On Financing to Advance Immunotherapy Pipeline
4个月前
HCW Biologics Advances Novel T-Cell Engager HCW11-018b for Solid Tumors with Unique Cis-Binding Mechanism
8个月前
CG Oncology Accelerates PIVOT-006 Phase 3 Timeline for Bladder Cancer Treatment
2年前
Pembrolizumab Demonstrates Sustained Survival Benefits in Advanced Melanoma After 10-Year Follow-Up
去年
Phase 1 Trial Shows Promise for IN-006 Inhaled COVID-19 Antibody Therapy
2年前
Pembrolizumab Shows Sustained Survival Benefit in Advanced Melanoma After 10-Year Follow-up
22天前
Psilera Appoints Neuroscience Veteran Allyson Gage, PhD, to Lead Phase 1 Trial of Neuroplastogen PSIL-006
第 1 页,共 48 页
上一页
下一页